161 related articles for article (PubMed ID: 21191065)
61. Galectin-1 mediates radiation-related lymphopenia and attenuates NSCLC radiation response.
Kuo P; Bratman SV; Shultz DB; von Eyben R; Chan C; Wang Z; Say C; Gupta A; Loo BW; Giaccia AJ; Koong AC; Diehn M; Le QT
Clin Cancer Res; 2014 Nov; 20(21):5558-69. PubMed ID: 25189484
[TBL] [Abstract][Full Text] [Related]
62. [Effect of feiliuping ointment and its disassembled prescriptions on dendritic cell of mice with transplanted Lewis lung cancer].
Zheng HG; Piao BK; Hua BJ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Dec; 30(12):1288-91. PubMed ID: 21302493
[TBL] [Abstract][Full Text] [Related]
63. Bronchial epithelial cells induce alternatively activated dendritic cells dependent on glucocorticoid receptor signaling.
Weitnauer M; Schmidt L; Ng Kuet Leong N; Muenchau S; Lasitschka F; Eckstein V; Hübner S; Tuckermann J; Dalpke AH
J Immunol; 2014 Aug; 193(3):1475-84. PubMed ID: 24965772
[TBL] [Abstract][Full Text] [Related]
64. Galectin-1 regulates tissue exit of specific dendritic cell populations.
Thiemann S; Man JH; Chang MH; Lee B; Baum LG
J Biol Chem; 2015 Sep; 290(37):22662-77. PubMed ID: 26216879
[TBL] [Abstract][Full Text] [Related]
65. Molecular modalities in the treatment of lung cancer.
Carbone DP
Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):142-7. PubMed ID: 10550839
[TBL] [Abstract][Full Text] [Related]
66. Interleukin-10-regulated tumour tolerance in non-small cell lung cancer.
Vahl JM; Friedrich J; Mittler S; Trump S; Heim L; Kachler K; Balabko L; Fuhrich N; Geppert CI; Trufa DI; Sopel N; Rieker R; Sirbu H; Finotto S
Br J Cancer; 2017 Nov; 117(11):1644-1655. PubMed ID: 29016555
[TBL] [Abstract][Full Text] [Related]
67. The administration of drugs inhibiting cholesterol/oxysterol synthesis is safe and increases the efficacy of immunotherapeutic regimens in tumor-bearing mice.
Lanterna C; Musumeci A; Raccosta L; Corna G; Moresco M; Maggioni D; Fontana R; Doglioni C; Bordignon C; Traversari C; Russo V
Cancer Immunol Immunother; 2016 Nov; 65(11):1303-1315. PubMed ID: 27520505
[TBL] [Abstract][Full Text] [Related]
68. Inhibiting galectin-1 reduces murine lung metastasis with increased CD4(+) and CD8 (+) T cells and reduced cancer cell adherence.
Ito K; Ralph SJ
Clin Exp Metastasis; 2012 Aug; 29(6):561-72. PubMed ID: 22484915
[TBL] [Abstract][Full Text] [Related]
69. [Metronomic chemotherapy combined with dendritic cell vaccine
inhibits VEGF secretion].
Zhou Y; Wang H; Zhong H
Zhongguo Fei Ai Za Zhi; 2013 Sep; 16(9):460-3. PubMed ID: 24034992
[TBL] [Abstract][Full Text] [Related]
70. Galectin-1 promotes immunoglobulin production during plasma cell differentiation.
Tsai CM; Chiu YK; Hsu TL; Lin IY; Hsieh SL; Lin KI
J Immunol; 2008 Oct; 181(7):4570-9. PubMed ID: 18802059
[TBL] [Abstract][Full Text] [Related]
71. Galectin-1 upregulates CXCR4 to promote tumor progression and poor outcome in kidney cancer.
Huang CS; Tang SJ; Chung LY; Yu CP; Ho JY; Cha TL; Hsieh CC; Wang HH; Sun GH; Sun KH
J Am Soc Nephrol; 2014 Jul; 25(7):1486-95. PubMed ID: 24511119
[TBL] [Abstract][Full Text] [Related]
72. Effect of galectin-1 on apoptosis of CD4(+) lymphocytes differentiated in vitro towards regulatory T cells.
Yakushina VD; Vasil'eva OA; Novitskii VV; Andreeva NV; Starikova EG; Tashireva LA; Prokhorenko TS; Zima AP; Ryazantseva NV
Bull Exp Biol Med; 2014 Mar; 156(5):669-72. PubMed ID: 24770755
[TBL] [Abstract][Full Text] [Related]
73. [IV.Clinical trial of immunotherapy for lung cancer].
Takenoyama M; Ichinose Y
Gan To Kagaku Ryoho; 2013 Aug; 40(8):1018-20. PubMed ID: 24151659
[No Abstract] [Full Text] [Related]
74. Epithelial Cell-Associated Galectin-3 Activates Human Dendritic Cell Subtypes for Pro-Inflammatory Cytokines.
Schroeder JT; Adeosun AA; Bieneman AP
Front Immunol; 2020; 11():524826. PubMed ID: 33154744
[TBL] [Abstract][Full Text] [Related]
75. [Effect of Epimedii Herba alcohol extract on inhibition of lung tumor growth and immunomodulatory].
Yuan JR; Wang CF; Song J; Zhao BJ; Dong ZB; Feng L; Jia XB
Zhongguo Zhong Yao Za Zhi; 2016 Jan; 41(1):112-117. PubMed ID: 28845651
[TBL] [Abstract][Full Text] [Related]
76. News & views in ... Immunotherapy.
Immunotherapy; 2011 Jan; 3(1):5-7. PubMed ID: 21174550
[No Abstract] [Full Text] [Related]
77. Impaired dendritic cell functions in lung cancer: a review of recent advances and future perspectives.
Wang JB; Huang X; Li FR
Cancer Commun (Lond); 2019 Jul; 39(1):43. PubMed ID: 31307548
[TBL] [Abstract][Full Text] [Related]
78. Galectin-9 expression clinically associated with mature dendritic cells infiltration and T cell immune response in colorectal cancer.
Wang Y; Zheng R; Zhang Y; Guo Y; Hui Z; Wang P; Sun Y
BMC Cancer; 2022 Dec; 22(1):1319. PubMed ID: 36527024
[TBL] [Abstract][Full Text] [Related]
79. Galectin-1 as a potential therapeutic target in autoimmune disorders and cancer.
Salatino M; Croci DO; Bianco GA; Ilarregui JM; Toscano MA; Rabinovich GA
Expert Opin Biol Ther; 2008 Jan; 8(1):45-57. PubMed ID: 18081536
[TBL] [Abstract][Full Text] [Related]
80. Extracellular vesicles derived from nasopharyngeal carcinoma induce the emergence of mature regulatory dendritic cells using a galectin-9 dependent mechanism.
Lefebvre A; Trioën C; Renaud S; Laine W; Hennart B; Bouchez C; Leroux B; Allorge D; Kluza J; Werkmeister E; Grolez GP; Delhem N; Moralès O
J Extracell Vesicles; 2023 Dec; 12(12):e12390. PubMed ID: 38117000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
